Aruna Bio, Inc.
PrivateLast Round
Grant
Jun 1, 2022
Total Funding Raised
$10.15M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aruna Bio, Inc. is a biotechnology company that develops a neural exosome platform to prepare medicine for the treatment of neural diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aruna Bio, Inc. Comparables
Compare Aruna Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VivaZome Therapeutics | 82% | |
| ReNeuron Group | 80% | |
| Florica Therapeutics | 79% |
Aruna Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2022 | ||||
| VC Round | Apr 14, 2021 | ||||
| Grant | Sep 12, 2019 | ||||
| VC Round | Jul 24, 2019 | ||||
| Angel | Sep 27, 2018 |
Key People
Founding team and executive leadership
Aruna Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eshelman Ventures | VC Round |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 125% MoM, reaching 5.9K.
- Aug 1, 2026
Open roles increased to 42, 2x the trailing average.
Aruna Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aruna Bio, Inc.'s valuation, stock price, and market status.
Is Aruna Bio, Inc. a public or private company?
Aruna Bio, Inc. is a private company.
What is the current stock price of Aruna Bio, Inc.?
Aruna Bio, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Aruna Bio, Inc. worth (valuation)?
Valuation information for Aruna Bio, Inc. is not publicly available.
Can I buy Aruna Bio, Inc. stock?
Aruna Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aruna Bio, Inc.'s last funding round?
Aruna Bio, Inc.'s most recent funding round was Grant on June 1, 2022.
Who are the main investors in Aruna Bio, Inc.?
Key investors in Aruna Bio, Inc. include Eshelman Ventures, National Institute of Neurological Disorders and Stroke.
Will Aruna Bio, Inc. IPO soon?
No public IPO plans have been announced for Aruna Bio, Inc..
How can I track Aruna Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aruna Bio, Inc.'s secondary market activity and sign up for updates.